SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Vincent van Gogh

PatientVincent van Gogh
Date of birth1990-03-30
IdentifiersMRN HR-NI010-SYN; SSN (made up) 000-10-3198
Document date2026-02-02
AuthorElise Verhoeven, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review, seen the same day by psychiatry with the coordinated specialty care team. [S]

History of Present Illness

Mr. van Gogh returns two weeks after his first visit, four weeks after aripiprazole 10 mg was started in hospital, and is seen by Dr. Feld of the coordinated specialty care team on the same day. He has taken every dose. He has had no confusion and hears nothing by day, but on some nights he still hears his name called as he falls asleep, and on those nights he feels for a while that people in the street are talking about him; by morning he knows this is not so. He sleeps about six hours with breaks. His mood is a little better: he feels less ashamed and has started to sketch, but still cannot paint for long. The passive thoughts that it would be easier not to wake up come less often; he has had no thoughts of suicide or self-harm. He drinks two or three glasses of wine most evenings and no spirits since discharge. He has noticed no restlessness or stiffness. He had his brain MRI and EEG this morning, after a night of shortened sleep as instructed. [S]

ElementDetail
Aripiprazole10 mg daily for four weeks, every dose taken
Psychotic symptomsHears his name called at sleep onset on some nights, with brief suspiciousness; none by day
MoodSomewhat better; PHQ-9 11; item 9 scored 1, less often
SleepAbout six hours, broken
AlcoholTwo or three glasses of wine most evenings; no spirits
Side effectsNone noticed

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; appetite normal
NeurologicalNegativeNo restlessness, stiffness, tremor, seizures, or episodes of lost time
Ears, nose, mouth, and throatNegativeLeft ear wound healed; hearing unchanged
PsychiatricPositiveNight-time perceptual disturbances at sleep onset; low mood improving; passive thoughts of not waking up less often; no suicidal intent or plan

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital)One tablet by mouth once dailyOral route2026-01-05 to 2026-02-02completedS
Aripiprazole 15 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-02-02 to 2026-02-16completedS
Naltrexone 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-02-02activeS
Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet by mouth dailyOral route2026-01-05 to 2026-07-20completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-02Body height170cmS
2026-02-02Body weight64.5kgS
2026-02-02Body mass index (BMI) [Ratio]22.3kg/m2S
2026-02-02Systolic blood pressure124mm[Hg]S
2026-02-02Diastolic blood pressure78mm[Hg]S
2026-02-02Heart rate82/minS
2026-02-02Respiratory rate14/minS
2026-02-02Body temperature36.6CelS
2026-02-02Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S

Physical Exam

Vital signs recorded on 2026-02-02; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 64.5 kg; waist 86 cm; blood pressure 124/78, pulse 82
Head and earsLeft ear wound healed, without infection
NeurologicalNo akathisia, rigidity, tremor, or abnormal movements; AIMS score 0
PsychiatricQuiet and cooperative; affect constricted but brighter; thought process organized; no hallucinations or delusions elicited today; insight good

Problems

ProblemClinical statusVerificationCodeProvenance
First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisisactiveprovisional F29S — Synthetic modern coding of the documented first crisis. Unspecified psychosis is coded because the cause is not yet established; the retrospective diagnoses stay in the claims.
Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking and its retrospective interpretation.
Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospitalactiveconfirmed Z91.52S — Synthetic modern coding of the documented injury; no detail of the injury is recorded.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Medication safetyAntipsychotic dose, adherence, and responseEvery visitCompleted todayAripiprazole 10 mg for four weeks with full adherence; partial response; increased to 15 mg
SurveyPsychotic and mood symptoms, and early warning signsEvery visitCompleted todayName called at sleep onset on some nights; brief night-time suspiciousness; none by day
ExaminationAkathisia, parkinsonism, and sedationEvery visit in the first months and after any dose changeCompleted todayNo akathisia, parkinsonism, or sedation
ExaminationAbnormal Involuntary Movement Scale (AIMS)Baseline, then every 6 monthsCompleted todayBaseline AIMS score 0, done with the consultation; repeat at six months
ExaminationWeight and BMIEvery visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)Completed today64.5 kg at four weeks, from 64.0 at intake
ExaminationWaist circumferenceBaseline, then yearlyCompleted today86 cm. This baseline was due at intake and was taken today instead; nothing was lost because weight was measured at intake. Waist is now part of the visit template
ExaminationBlood pressureBaseline, 12 weeks, then yearlyUp to date128/80 at intake; 124/78 today
LaboratoryFasting glucose and A1cBaseline, 12 weeks to 4 months, then yearlyUp to dateFasting glucose 91 mg/dL and A1c 5.3% at intake; next at 12 weeks
LaboratoryFasting lipid panelBaseline, 12 weeks to 4 months, then yearlyUp to dateTotal cholesterol 184, LDL 106, HDL 52, triglycerides 130 mg/dL at intake; next at 12 weeks
LaboratoryProlactinIf symptoms of high prolactinNot indicatedAripiprazole rarely raises prolactin; no symptoms
LaboratoryElectrocardiogramBefore starting if there are cardiac risk factors or QT-prolonging drugsNot indicatedNo cardiac history, fainting, or QT-prolonging drugs; aripiprazole has little effect on the QT interval
LaboratoryFirst-episode workup (MRI and EEG)Once, in the first-episode workupCompleted todayBrain MRI and sleep-deprived EEG done this morning; results pending
SurveyDepression measure (PHQ-9)Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodicallyCompleted todayPHQ-9 11, from 13; item 9 scored 1
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayPassive thoughts of not waking up less often, no intent or plan; safety plan reviewed; no firearm access; medicines two weeks at a time; the 988 Suicide & Crisis Lifeline in his phone
Self-managementSleepEvery visitCompleted todayAbout six hours, broken; regular times and less evening coffee agreed
SurveyDrinking (AUDIT-C and PEth)PEth at intake and at each check while drinking continues; AUDIT-C yearlyUp to dateAUDIT-C 9 and PEth 284 ng/mL at intake; two or three glasses most evenings now
Medication safetyNaltrexone: liver tests and opioid exposureLiver tests before starting, then at 1 to 3 months and every 6 to 12 monthsCompleted todayAST 58, ALT 44 U/L at intake, well below three times the upper limit; urine drug test negative for opioids; naltrexone started
Medication safetyThiamineWhile drinking heavilyCompleted todayTaking thiamine 100 mg daily since the hospital
ReferralPsychiatry consultationAt the start of treatment for a first episodeCompleted todaySeen by Dr. Feld today
Self-managementCoordinated specialty care engagementOngoing, for up to two to three yearsCompleted todayEnrolled today; first meetings with the care coordinator and therapist booked

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Six-week visit in four weeks with liver tests, PEth, the PHQ-9, and the MRI and EEG results. Care coordinator by phone weekly. Call at once for restlessness, voices by day, or dark thoughts. Next scheduled visit 2026-03-02: six-week review: symptoms, side effects, alcohol, sleep, and test results. [S]